Prof. Zeiser is being honored for his groundbreaking work in the research and treatment of blood cancers, with a particular focus on transplant rejection and the immunological “cloaking” of tumors.
His research aims to provide new molecular insights into immune processes in tumor diseases and related rejection reactions after transplantation, with the ultimate goal of developing new drugs through clinical trials
The Leibniz Prize further cements Prof. Zeiser’s status as a leading figure in the field of blood cancer research and treatment and recognizes his significant contributions to improving patient outcomes and advancing our understanding of the complex immunological processes in cancer.
The €2.5 million prize is considered the most prestigious research award in Germany.
Congratulations to these achievements!
